ecrin-mdr-crcClinical2013Colorectal Cancer MetastaticColorectal NeoplasmsUnresectable Wild-Type KRAS Metastatic Colorectal CancerMetastatic colorectal cancerUnresectable Wild-type Kras Metastatic Colorectal CancerMetastatic Colorectal CancerColorectal NeoplasmsColorectal Cancer MetastaticInterventionalhttps://newmdr.ecrin.org/Study/2149166AustriaBelgiumIrelandItalyIsraelFranceSpain10capecitabinefluorouracileIrinotecanPanitumumabWild-type RAS metastatic colorectal canceroxaliplatinCetuximablévofolinate de calciumBevacizumabECRIN MDRNot providedfalseMulti-Line Therapy Trial in Unresectable Metastatic Colorectal CancerSTRATEGIC-1 is a study designed to determine the best sequence of therapy in patients with metastatic colorectal cancer.2013-10-152149166NCT019106102013-001928-19